220 related articles for article (PubMed ID: 29214764)
1. Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma.
Lee T; Park BG; You E; Cho YU; Jang S; Lee SM; Suh C; Park CJ
Ann Lab Med; 2018 Mar; 38(2):172-175. PubMed ID: 29214764
[No Abstract] [Full Text] [Related]
2. [Treatment of diffuse large B-cell lymphosarcoma with involvement of bone marrow in an old female patient].
Zamiatina VI; Kravchenko SK; Giliazitdinova EA; Magomedova AU; Vorob'ev IA; Gotman LN; Kaplanskaia IB; Kesel'man SA; Obukhova TN; Sakhibov IaD; Shevelev AA; Kremenetskaia AM
Ter Arkh; 2008; 80(7):54-7. PubMed ID: 18763597
[No Abstract] [Full Text] [Related]
3. Histologic transformation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Lee E; Kim TM; Lim Y; Jeon YK; Go H; Kim CW; Heo DS
J Clin Oncol; 2013 Jul; 31(19):e332-4. PubMed ID: 23715578
[No Abstract] [Full Text] [Related]
4. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma.
Cornish N; Maybury B; Otton S
Br J Haematol; 2018 Jan; 180(2):176. PubMed ID: 29048103
[No Abstract] [Full Text] [Related]
5. The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma.
Kim HK; Park CJ; Jang S; Cho YU; Park SH; Choi J; Park CS; Huh J; Chung YH; Lee JH
Ann Lab Med; 2015 Jan; 35(1):152-4. PubMed ID: 25553299
[No Abstract] [Full Text] [Related]
6. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
Yang QX; Pei XJ; Tian XY; Li Y; Li Z
Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.
Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C
Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186
[No Abstract] [Full Text] [Related]
8. My turn.
Fotis MA
Am J Health Syst Pharm; 2008 Aug; 65(15):1471-6. PubMed ID: 18653819
[No Abstract] [Full Text] [Related]
9. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
[No Abstract] [Full Text] [Related]
10. Multiple cytokine-producing aggressive EBV-positive diffuse large B cell lymphoma, not otherwise specified with hemophagocytic syndrome.
Nakayama S; Morita Y; Espinoza JL; Rai S; Taniguchi Y; Taniguchi T; Miyake Y; Tanaka H; Ashida T; Matsumura I
Ann Hematol; 2020 Feb; 99(2):381-383. PubMed ID: 31768673
[No Abstract] [Full Text] [Related]
11. [Epstein-Barr virus-positive diffuse large B-cell lymphoma following peripheral T-cell lymphoma, not otherwise specified: report of a case].
Zhang F; Liu YH; Zhuang HG; Li L; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):414-5. PubMed ID: 21055162
[No Abstract] [Full Text] [Related]
12. Primary Lymphoma of Liver-a Rare Space-Occupying Lesion.
Patkar S; Dutt K; Shah A; Sengar M; Goel M
J Gastrointest Cancer; 2020 Sep; 51(3):1057-1060. PubMed ID: 32333249
[No Abstract] [Full Text] [Related]
13. Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
Jin X; Liu H; Li J; Xiao X; Yuan X; Chen P; Chen B; Liang Y; Huang F
J Zhejiang Univ Sci B; 2023 Aug; 24(8):711-722. PubMed ID: 37551557
[TBL] [Abstract][Full Text] [Related]
14. Quantification of plasma Epstein-Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma.
Law MF; Poon WL; Ng KS; Chan HN; Lai HK; Ha CY; Ng C; Yeung YM; Yip SF
Ann Hematol; 2012 May; 91(5):789-791. PubMed ID: 21881823
[No Abstract] [Full Text] [Related]
15. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
[No Abstract] [Full Text] [Related]
16. BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
Palickova M; Mocikova H; Vernerova Z; Campr V; Kozak T
Leuk Lymphoma; 2013 Sep; 54(9):2081-2. PubMed ID: 23311295
[No Abstract] [Full Text] [Related]
17. Intravascular large B-cell lymphoma--a diagnostic dilemma.
Ramkumar B; Hutchison R; Khadim H; Gajra A
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):e18-21. PubMed ID: 24060286
[No Abstract] [Full Text] [Related]
18. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
19. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
Wang C; Li W; Liu C; He H; Bai O
Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
[TBL] [Abstract][Full Text] [Related]
20. Hemophagocytic syndrome in ileum-origin B-cell lymphoma.
Motegi S; Nishizaki Y; Muramatsu C; Nakamura H; Kobayashi F; Shiozawa H; Kamochi J; Itakura M; Shibuya M; Ogawa T; Matsuzaki S
J Gastroenterol; 2003; 38(10):995-9. PubMed ID: 14614609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]